358 related articles for article (PubMed ID: 16606781)
1. Most patients with multiple sclerosis or a clinically isolated demyelinating syndrome should be treated at the time of diagnosis.
Frohman EM; Havrdova E; Lublin F; Barkhof F; Achiron A; Sharief MK; Stuve O; Racke MK; Steinman L; Weiner H; Olek M; Zivadinov R; Corboy J; Raine C; Cutter G; Richert J; Filippi M
Arch Neurol; 2006 Apr; 63(4):614-9. PubMed ID: 16606781
[No Abstract] [Full Text] [Related]
2. Early treatment: PreCISe-ly what the patient needs.
Montalban X
J Neurol Sci; 2009 Dec; 287 Suppl 1():S2-6. PubMed ID: 20106344
[TBL] [Abstract][Full Text] [Related]
3. Not every patient with multiple sclerosis should be treated at time of diagnosis.
Pittock SJ; Weinshenker BG; Noseworthy JH; Lucchinetti CF; Keegan M; Wingerchuk DM; Carter J; Shuster E; Rodriguez M
Arch Neurol; 2006 Apr; 63(4):611-4. PubMed ID: 16606780
[No Abstract] [Full Text] [Related]
4. Prognostic value of cerebrospinal fluid analysis at the time of a first demyelinating event.
Gout O; Bouchareine A; Moulignier A; Deschamps R; Papeix C; Gorochov G; Héran F; Bastuji-Garin S
Mult Scler; 2011 Feb; 17(2):164-72. PubMed ID: 20965960
[TBL] [Abstract][Full Text] [Related]
5. New options for early treatment of multiple sclerosis.
Tintoré M
J Neurol Sci; 2009 Feb; 277 Suppl 1():S9-S11. PubMed ID: 19200870
[TBL] [Abstract][Full Text] [Related]
6. Effect of early interferon beta-1a therapy on conversion to multiple sclerosis in Iranian patients with a first demyelinating event.
Pakdaman H; Sahraian MA; Fallah A; Pakdaman R; Ghareghozli K; Ghafarpour M; Rahimian E; Shirani A
Acta Neurol Scand; 2007 Jun; 115(6):429-31. PubMed ID: 17511854
[TBL] [Abstract][Full Text] [Related]
7. Early multiple sclerosis: to treat or not to treat?
Roach ES
Arch Neurol; 2006 Apr; 63(4):619. PubMed ID: 16606782
[No Abstract] [Full Text] [Related]
8. No shortcuts to outcome in MS clinical trials?
Koch-Henriksen N
Neurology; 2009 Feb; 72(8):686-7. PubMed ID: 19237696
[No Abstract] [Full Text] [Related]
9. CIS case studies.
Tumani H; Sapunova-Mayer I; Süssmuth SD; Hirt V; Brettschneider J
J Neurol Sci; 2009 Dec; 287 Suppl 1():S7-10. PubMed ID: 20106350
[TBL] [Abstract][Full Text] [Related]
10. Management of worsening multiple sclerosis with mitoxantrone: a review.
Fox EJ
Clin Ther; 2006 Apr; 28(4):461-74. PubMed ID: 16750460
[TBL] [Abstract][Full Text] [Related]
11. A single, early magnetic resonance imaging study in the diagnosis of multiple sclerosis.
Rovira A; Swanton J; Tintoré M; Huerga E; Barkhof F; Filippi M; Frederiksen JL; Langkilde A; Miszkiel K; Polman C; Rovaris M; Sastre-Garriga J; Miller D; Montalban X
Arch Neurol; 2009 May; 66(5):587-92. PubMed ID: 19433658
[TBL] [Abstract][Full Text] [Related]
12. Definition of responder: introduction.
Comi G
Neurol Sci; 2008 Sep; 29 Suppl 2():S209-10. PubMed ID: 18690493
[TBL] [Abstract][Full Text] [Related]
13. To treat, or not to treat: the therapeutic dilemma of idiopathic monosymptomatic demyelinating syndromes.
Frohman EM; Racke M; van Den Noort S
Arch Neurol; 2000 Jul; 57(7):930-2. PubMed ID: 10891973
[No Abstract] [Full Text] [Related]
14. Shifting the paradigm toward earlier treatment of multiple sclerosis with interferon beta.
Comi G
Clin Ther; 2009 Jun; 31(6):1142-57. PubMed ID: 19695384
[TBL] [Abstract][Full Text] [Related]
15. Multiple sclerosis risk in radiologically uncovered asymptomatic possible inflammatory-demyelinating disease.
Siva A; Saip S; Altintas A; Jacob A; Keegan BM; Kantarci OH
Mult Scler; 2009 Aug; 15(8):918-27. PubMed ID: 19667020
[TBL] [Abstract][Full Text] [Related]
16. Predictive factors for multiple sclerosis in patients with clinically isolated spinal cord syndrome.
Ruet A; Deloire MS; Ouallet JC; Molinier S; Brochet B
Mult Scler; 2011 Mar; 17(3):312-8. PubMed ID: 21071465
[TBL] [Abstract][Full Text] [Related]
17. [The role of the spontaneous occurrence of Pulfrich's stereophenomenon in the diagnosis of demyelinating diseases of the central nervous system].
Bieganowski L; Lubinski I; Kowalczyk A
Klin Oczna; 1998; 100(2):81-4. PubMed ID: 9695541
[TBL] [Abstract][Full Text] [Related]
18. Acute inflammatory demyelinating optic neuritis: evidence-based visual and neurological considerations.
Abou Zeid N; Bhatti MT
Neurologist; 2008 Jul; 14(4):207-23. PubMed ID: 18617847
[TBL] [Abstract][Full Text] [Related]
19. [Isolated central nervous system demyelinating syndrome as the clinical expression of late multiple sclerosis. Report of one case].
Zambrano H; Cartier L; Vergara C; López E
Rev Med Chil; 1998 Mar; 126(3):309-14. PubMed ID: 9674302
[TBL] [Abstract][Full Text] [Related]
20. [Use of magnetic resonance imaging in the diagnosis and prognosis of multiple sclerosis].
Zivadinov R; Sepcić J
Lijec Vjesn; 2006; 128(9-10):295-308. PubMed ID: 17128669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
